Chiesi Group and Apotex Inc. finalize agreement for acquisition of Ferriprox® (deferiprone)

13-01-2020

Chiesi and Durham Bulls Partnership Culminates in $15,000 to Triangle Nonprofits

04-09-2019

Chiesi Group confirms positive trend to date for 2019

09-07-2019

Chiesi Group is the largest pharmaceutical group in the world to be awarded B Corp certification

06-06-2019

Triangle Business Journal Recognizes Chiesi USA, Inc. With Third Consecutive Corporate Philanthropy Award

05-06-2019

Paolo Chiesi is Appointed Honorary Doctor at Karolinska Institutet

15-05-2019

Chiesi Named Signature Sponsor of the Triangle March for Babies Walk & 5K Run

26-04-2019

Chiesi and Durham Bulls Partnership Steps up to Bat for Local Charities

22-04-2019

Chiesi USA Promotes Medical Affairs Head to Support Continued Corporate Growth

16-04-2019

Chiesi USA, Inc. Moves to New Headquarters in Regency Woods II

26-02-2019

Chiesi Joins National Organization for Rare Disorders (NORD)® Corporate Council

21-02-2019

Chiesi USA, Inc. Receives Top Employer in the US Certification for 2019

31-01-2019

Chiesi in the Community Donates approximately $850,000 in 2018

28-01-2019

Chiesi USA Attains Public Benefit Corporation Status, Pledges to Advance Positive Community Impact

11-01-2019

Chiesi Salutes Neonatal Intensive Care Unit Staff in Honor of Prematurity Awareness Month®

14-11-2018

Chiesi Salutes Nurses Surrounding Neonatal Nurses Day 2018

18-09-2018

Chiesi Partnership with Durham Bulls Closes Season with $15,000 to Area Nonprofits

06-09-2018

Chiesi USA, Inc. Named a Best Place to Work

22-08-2018

Chiesi Foundation Onlus Issues 2018 Call for Scientific Research Proposals

14-08-2018

Chiesi and Holostem Announce FDA Orphan Drug Designation for GPLSCD01 for treatment of Limbal Stem Cell Deficiency (LSCD)

12-06-2018

175 Regency Woods Place, Suite 600, Cary, NC 27518
PP-MULTI-0024 V5.0

CHIESI ON THE WEB